Overview of Diclo-5

Quick Facts

Property	Description
Active Ingredient	Diclofenac (Sodium or Potassium salt)
Pharmacological Class	Non-Steroidal Anti-Inflammatory Drug (NSAID)
Origin	Synthetic (Acetic Acid Derivative)
Common Use	Relief of pain, inflammation, and fever
Forms	Tablets, Capsules, Topical Gels, Solutions

The pharmaceutical product Diclo-5 is a preparation containing the active substance Diclofenac, used for its anti-inflammatory and analgesic properties. It is a medicine utilized in managing symptoms associated with inflammation and pain across various clinical contexts.

What Type of Medicine is Diclo-5?

Diclo-5 is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID), belonging to the chemical subgroup of acetic acid derivatives. The core substance, Diclofenac, is a synthetic compound, commonly prepared as a diclofenac sodium or potassium salt, which aids in its systemic delivery and stability. This classification signals that the medicine is designed to counteract the body's processes of inflammation, distinguishing it from simple pain relievers that lack substantial anti-inflammatory effects. Diclofenac is commonly available in both Prescription-only (Rx) and lower-concentration Over-The-Counter (OTC) forms, reflecting its versatility for different patient groups and levels of required clinical oversight.

Composition and Available Forms of Diclofenac

The essential active ingredient in Diclo-5 is Diclofenac, and it is generally formulated as a single-ingredient product. To ensure optimal route of administration, Diclofenac is made available in diverse dosage forms, including various types of oral tablets and capsules, which provide systemic absorption, as well as several types of topical preparations such as gels, solutions, and patches. These different forms permit either targeted, localized application (topical) or broad internal effect (oral), adapting the medicine to distinct therapeutic needs.

General Purpose: Anti-inflammatory and Analgesic Relief

The general purpose of Diclo-5 is to deliver combined anti-inflammatory and analgesic relief by affecting the chemical causes of pain and swelling. Diclofenac acts as a Cyclooxygenase (COX) inhibitor, a mechanism that reduces the production of prostaglandins, which are the chemical mediators responsible for generating pain signals and initiating swelling. This action provides relief from discomfort, fever, and inflammation, positioning it as a symptomatic treatment. Diclofenac serves as both an analgesic and an anti-inflammatory agent. This means the medicine is designed to help ease both the feeling of pain and the underlying inflammation, offering symptomatic relief in scenarios where inflammation contributes to discomfort.

Regulatory References

NIH Bookshelf Systematic Review (See:)

What side effects are possible with Diclo-5?

Possible Side Effects and Safety Information: Diclo-5

Diclo-5, a formulation containing diclofenac, is a nonsteroidal anti-inflammatory drug (NSAID) primarily used for pain and inflammation relief. While generally well-tolerated when used as directed, it can cause side effects. Awareness of these is crucial for safe use.

Common Side Effects

These effects are generally mild and may resolve as your body adjusts. If they persist or worsen, consult your healthcare provider.

System	Side Effect
Gastrointestinal	Indigestion, nausea, stomach pain, diarrhea
Central Nervous System	Headache, dizziness
Dermatological	Rash, itching

Serious Side Effects and Warnings

Diclofenac carries a Boxed Warning regarding serious cardiovascular and gastrointestinal risks. Do not use Diclo-5 before consulting your doctor if you have a history of heart attack, stroke, or heart failure, or if you have recently had or are about to have heart bypass surgery (CABG).

Gastrointestinal Risk: Serious events like bleeding, ulceration, and perforation of the stomach or intestines can occur without warning. This risk is higher with prolonged use, in older patients, or in those with a history of GI disease.

Cardiovascular Risk: Diclofenac may increase the risk of serious thrombotic events, including myocardial infarction (heart attack) and stroke. This risk can occur early in treatment and may increase with duration of use.

Other Serious Effects may include liver problems, kidney dysfunction, and severe allergic reactions. Seek emergency medical attention immediately if you experience chest pain, sudden weakness, shortness of breath, black or bloody stools, or severe skin reactions. Always use the lowest effective dose for the shortest possible duration.

Overdose and Emergency Response

Diclo-5 Overdose and when to seek help

The official regulatory documents define the Diclofenac (Diclo-5) overdose profile by documenting the expected clinical signs and mandated emergency actions.

Documented Clinical Manifestations

Symptoms following acute overexposure are often limited, encompassing gastrointestinal effects such as nausea, vomiting, diarrhea, and epigastric pain. Central nervous system effects such as lethargy, drowsiness, headache, and tinnitus are also documented in regulatory labeling. Severe, life-threatening outcomes can include acute renal failure, hypertension, respiratory depression, and, in rare instances, coma. The elderly and individuals with pre-existing renal or hepatic impairment may face increased risk of severe consequences.

Mandated Emergency Action

In the event of a suspected overdose, patients must seek immediate medical attention. This action is critical because official labeling states that no specific antidote is known for Diclofenac overdose. Management is strictly limited to providing symptomatic and supportive care. Following a significant ingestion, hospital monitoring is required, including the observation of vital signs and renal function. For severe manifestations, such as respiratory depression or acute organ damage, contacting emergency services is required. Gastric decontamination measures, such as activated charcoal, may be utilized as part of the initial supportive treatment.

Therapeutic Uses of Diclo-5

Main Uses of Diclo-5

Diclo-5 is a medication used primarily to manage pain and reduce inflammation. It belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). By inhibiting the production of prostaglandins—chemicals in the body that signal pain and contribute to swelling—it helps alleviate symptoms associated with several acute and chronic conditions.

Inflammatory Conditions

Diclo-5 is commonly utilized to treat various forms of arthritis and inflammatory joint disorders. These include:

Osteoarthritis: Helping to manage the pain and joint stiffness caused by the breakdown of cartilage.
Rheumatoid Arthritis: Addressing the chronic inflammation of the joints and reducing associated swelling.
Ankylosing Spondylitis: Relieving discomfort and improving mobility in patients with this chronic inflammatory condition affecting the spine.

Acute Pain Management

Beyond chronic conditions, Diclo-5 is effective for the short-term relief of acute pain. Its applications include:

Soft Tissue Injuries: Management of pain resulting from strains, sprains, and sports injuries.
Post-Operative Recovery: Reducing inflammation and pain following surgical procedures.
Menstrual Pain: Alleviating the discomfort associated with primary dysmenorrhea.
Dental Pain: Providing relief for acute pain following dental interventions or oral surgery.

Benefits of Treatment

The primary benefit of Diclo-5 is the improvement of physical function and quality of life through the reduction of physical distress. By minimizing swelling and tenderness in the affected areas, the medication can help restore a greater range of motion and allow individuals to engage more comfortably in daily activities. Its targeted action on inflammatory pathways makes it a versatile option for both localized injury and systemic joint issues.

Regulatory References

NIH MedlinePlus overview on Diclofenac

Eligibility and Restrictions for Use

Who Can and Cannot Use Diclo-5?

The eligibility for Diclo-5 (Diclofenac) is strictly governed by the patient's underlying health status and age, as defined by major regulatory authorities.

Contraindicated Populations (Must Not Use)

Category	Contraindication
Cardiovascular Status	Established severe heart failure (NYHA Class II-IV), ischaemic heart disease, or use following CABG surgery (Coronary Artery Bypass Graft).
Gastrointestinal Health	Active gastrointestinal bleeding, perforation, or ulcers.
Allergy	History of asthma, urticaria, or allergic reactions to aspirin or other NSAIDs.
Organ Failure	Severe hepatic failure or severe renal failure.

Restricted and Conditional Use

Pregnancy: Contraindicated in the third trimester (from about 30 weeks gestation). Use in the first and second trimesters is generally not recommended or advised only after careful assessment of necessity.
Age Limits: Systemic forms are often not established for use in children under a specific age (e.g., typically <12 or <14 years). Use in older adults requires particular caution due to increased susceptibility to serious gastrointestinal and renal adverse effects.
Other Conditions: Patients with risk factors for cardiovascular events (e.g., hypertension) or a history of GI disease must be treated with the lowest effective dose for the shortest duration possible, as mandated by regulatory labeling.

What should I know about interactions with other medicines?

Diclo-5, which contains the non-steroidal anti-inflammatory drug (NSAID) diclofenac, has several documented interactions that require careful consideration based on regulatory safety information.

Contraindicated and High-Risk Combinations

Other NSAIDs and Aspirin: Concomitant use with other NSAIDs (e.g., ibuprofen, naproxen) or aspirin is generally restricted, as this combination markedly increases the risk of serious gastrointestinal adverse events, including ulceration, bleeding, and perforation, without providing additional therapeutic benefit. This combination may also attenuate the cardioprotective effect of low-dose aspirin.
Coronary Artery Bypass Graft (CABG) Surgery: Diclofenac is contraindicated for the treatment of peri-operative pain in the setting of CABG surgery.

Specific Pharmacokinetic and Additive Risks

Anticoagulants and Antiplatelet Agents: Co-administration with drugs like warfarin, antiplatelets, or selective serotonin reuptake inhibitors (SSRIs) may enhance the risk of bleeding due to the additive antiplatelet effects of diclofenac. Close monitoring of coagulation parameters is often required.
CYP2C9 Enzyme: Diclofenac is primarily metabolized by the hepatic enzyme CYP2C9. Drugs that inhibit this enzyme (e.g., voriconazole) can significantly increase diclofenac exposure, raising the risk of adverse effects. Conversely, inducers of CYP2C9 may decrease diclofenac concentration.
Alcohol: Consumption of alcohol alongside diclofenac is strongly advised against, as it can significantly increase the probability of developing serious gastrointestinal bleeding and mucosal irritation.
Certain Antihypertensives: Diclofenac can decrease the antihypertensive effect of some blood pressure medications (e.g., ACE inhibitors, diuretics, ARBs) and may increase the risk of renal impairment, particularly in elderly or volume-depleted patients. The addition of potassium-sparing diuretics may also increase the risk of hyperkalemia.

Mechanism of Action

The mechanism of action for Diclofenac (Diclo-5) is multifaceted, utilizing both enzyme inhibition and direct modulation of neural excitability.

Blocking the Synthesis of Inflammatory Mediators

This domain covers the drug’s principal target: the Cyclooxygenase (COX) enzymes, specifically inhibiting the production of prostaglandins. Diclofenac acts within the Arachidonic Acid Cascade to block the synthesis of key chemical messengers, such as prostaglandin E2 (PGE2), which are chemical mediators of nociceptor sensitization and factors that influence the hypothalamic temperature set-point. This suppression of mediator production results in a reduction of pathway output and modifies the signaling dynamics within the inflammatory pathways.

Modulating Peripheral Neural Signals

This mechanistic domain highlights a prostaglandin-independent action where the drug directly influences the electrical stability of peripheral nociceptive neurons. By activating ATP-sensitive potassium channels (KATP), Diclofenac promotes the hyperpolarization of these cells, which results in the neurons becoming less excitable and dampens their capacity for signal propagation. This targeted interference with nerve signaling supplements the chemical blockade, influencing the regulation of action potential generation within peripheral pathways.

Dosage and Administration Information

Administration Scope

Element	Official Guideline Statement
Route of Administration	Oral, Intramuscular (IM), Intravenous (IV), and Topical (gel/solution) are approved routes.
Dosing Schedule	Labeled adult regimens range from 75 mg to 150 mg total daily dose. Extended-release forms are typically 100 mg once daily. Acute use, such as for migraine, utilizes a single 50 mg dose.
Timing in Relation to Meals	Certain oral tablets are advised to be taken before meals. Specific oral powder forms should be consumed immediately, as taking them with food may reduce effectiveness.
Preparation Requirements	Oral powder must be mixed immediately with a small amount of water for consumption. IV solutions require dilution and buffering with sodium bicarbonate prior to infusion.
Age-Group Administration Rules	Older Adults should initiate therapy using the lowest effective dosage for the shortest duration. Standard tablets are not generally recommended for children under 14 years.
Special Procedural Conditions	The use of parenteral forms (IM/IV) is generally limited to a maximum of two days. Delayed-release tablets must be swallowed whole and not crushed to maintain integrity.

Use Protocol Summary

The official instructions establish a structured protocol that begins by defining multiple administration routes, each tied to specific preparation requirements (e.g., dilution for IV forms). This protocol mandates precise dose ranges and frequencies that must not exceed a strict daily maximum and is governed by the overarching principle to use the lowest effective dose for the shortest duration necessary. These labeled procedures ensure a uniform, compliant pattern for the administration of the medicine.

Recent Clinical Evidence

Diclo-5: Recent Clinical Evidence

Phase I and II Trials

Early research suggests the drug may act by enhancing a specific cellular pathway associated with inflammation, with the known primary mechanism involving the inhibition of cyclooxygenase (COX) enzymes. These initial stages focused primarily on establishing the drug’s metabolic characteristics, dosage tolerance, and preliminary safety parameters. Trials identified a side-effect profile that included transient gastrointestinal symptoms, such as nausea and headache, in a small percentage of participants.

Phase III Randomized Controlled Trials (RCTs)

Large-scale research has focused on the drug’s impact on function and reported pain scores in individuals with conditions such as osteoarthritis and acute moderate to severe pain.

Joint Function: Studies have investigated the effect of the drug on joint mobility, with results describing a change in measured mobility compared to placebo groups in participants with knee or hip osteoarthritis. The research examined whether this approach was associated with changes in reported pain levels over observation periods, typically spanning a 12-week intervention.
Pain Levels: Studies reported findings of reduced pain intensity in the treatment groups versus placebo in settings like post-operative pain and acute low back pain. One study using a suppository formulation as an adjunct to opioids for cancer pain reported a statistically significant reduction in pain scores and the incidence of breakthrough pain over six days of medication.

Combination Therapy and Formulation Research

Research has explored the use of Diclo-5 in conjunction with standard-of-care treatments and in novel formulations.

Combination Use: The evaluation of Diclo-5 alongside a muscle relaxant in an injection for acute low back pain investigated whether the combination led to different outcome measures compared to Diclo-5 alone. Other studies are evaluating the prophylactic use of topical formulations to mitigate the risk of adverse events associated with certain chemotherapy treatments.
Administration Context: The study protocols note that oral formulations were administered with food, a factor that may influence the drug's overall absorption profile.

Frequently Asked Questions (FAQ)

Common questions about Diclo-5 (FAQ)

Q: How quickly can a person expect Diclo-5 to start working?

A: Regulatory documents indicate that measurable levels of the active ingredient in the bloodstream can be detected in some people within 10 minutes of taking certain oral forms. Peak plasma levels, which correlate with the strongest effect, are typically reached in about one hour in fasting, healthy adults.

Q: How long does the effect of one dose of Diclo-5 usually last?

A: Official information regarding how the drug is processed by the body indicates that the terminal half-life of the active ingredient is approximately 1.9 hours. The half-life reflects the amount of time it takes for half of the substance to be eliminated from the body.

Q: Can older adults safely use Diclo-5?

A: Official guidelines state that older adults may be more susceptible to certain serious side effects, particularly those affecting the stomach, intestines, and kidneys. Therefore, official product information indicates that treatment should follow the principle of using the lowest effective dosage for the shortest duration.

Q: Is it true that Diclo-5 can affect blood pressure?

A: Yes, regulatory documents mention that drugs in this class (NSAIDs) can lead to the appearance of high blood pressure or may worsen already existing hypertension. Additionally, it may cause a reduced effectiveness when taken alongside certain blood pressure-lowering medications.

Q: Is Diclo-5 known to cause sleepiness or drowsiness?

A: Drowsiness is specifically listed in the official labeling for Diclo-5 as a commonly reported side effect. It is noted as a possible side effect; however, information on how a person's body adjusts is typically a matter for clinical discussion.

Q: Does Diclo-5 interact with common vitamins or supplements?

A: While specific interactions for every single vitamin or supplement are not always detailed, official information notes that healthcare providers should be informed about all medicines and supplements being taken. This is because non-prescription products are not tested in the same way as prescription medicines for all possible interactions.

Q: Is there a maximum amount of time a person is generally advised to use Diclo-5?

A: Due to potential safety risks, particularly involving the heart and stomach, regulatory guidance strongly advises using the lowest effective daily dose for the shortest duration possible. The treatment is generally recommended to be short-term rather than for prolonged use.

Q: What happens if I forget to take a dose of Diclo-5?

A: General instructions often state that if a dose is missed, the next dose is taken at the regularly scheduled time. It is also often noted that double doses should be avoided to compensate for the one that was missed.

Q: Can Diclo-5 be used for headaches or migraines?

A: Specific formulations of the active ingredient are officially indicated for the acute treatment of migraine attacks in adults. This means these particular preparations are authorized for relieving the sudden onset of a migraine, with or without an aura.

Q: Is Diclo-5 addictive?

A: Diclo-5 is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID) and is not classified as an opioid medication. It is not designated as a controlled substance with the abuse and dependence potential associated with narcotic pain relievers.

Q: What does 'contraindicated' mean in the context of Diclo-5?

A: A contraindication is a term used in medical documents to mean a condition or factor that absolutely prevents the safe use of a drug. Official documents list specific health issues, such as severe heart failure or active ulcers, and these are conditions that prevent the use of the drug, as official labeling indicates that its use would likely result in harm.

Q: What types of heart conditions are a concern when considering Diclo-5?

A: Official warnings strongly advise against using Diclo-5 if there are certain existing cardiovascular issues. These include established heart conditions such as ischaemic heart disease, peripheral arterial disease, cerebrovascular disease, and moderate to severe heart failure.

Q: Are there specific official warnings for people with stomach ulcers who use Diclo-5?

A: Yes. People who have a prior history of peptic ulcer disease or gastrointestinal bleeding are at a greater risk for serious stomach and intestinal side effects, including bleeding, ulceration, and perforation. Official guidelines indicate that particular caution and monitoring may be warranted in these patients.

Q: What research is available on the long-term effects of Diclo-5 use?

A: Official warnings note that the increased risk of serious cardiovascular events, such as heart attack and stroke, may occur early in treatment and can increase with duration of use. This risk is a particular concern for long-term, high-dose use of the medication.

Q: What should I do if I think I've had a bad reaction to Diclo-5?

A: For mild and common side effects, patient information often suggests resting, staying hydrated, or managing the symptom. If the reaction does not go away, gets worse, or if a serious event is suspected, immediate medical attention is indicated.

Q: Are there specific population groups where the risk of side effects from Diclo-5 is higher?

A: Yes, official documents specify higher-risk groups. These include older adults, patients with a history of stomach or intestinal diseases, and those who have pre-existing cardiovascular risk factors like hypertension or high cholesterol.

Q: Does Diclo-5 affect liver function tests?

A: Official labeling states that the drug may be associated with elevated results on liver function tests. For patients receiving long-term therapy, the need for periodic monitoring of these tests is indicated in the prescribing information.

Q: What is known about Diclo-5 use in children?

A: Official guidelines state that standard oral tablets are not generally recommended for children under 14 years of age. Use in the pediatric population is only established for specific indications, doses, and formulations as detailed in the official prescribing information.

Q: Is Diclo-5 known to cause photosensitivity (increased sun sensitivity)?

A: Official adverse reaction lists include photosensitivity, which is an increased sensitivity to sunlight. Topical formulations, such as gels, specifically carry warnings about avoiding or minimizing exposure to natural and artificial sunlight during treatment.

Q: Can Diclo-5 be used for inflammatory conditions other than pain?

A: Yes, the drug is officially indicated for the relief of both the pain and the signs and symptoms associated with specific inflammatory conditions. These include chronic conditions such as osteoarthritis and rheumatoid arthritis.

Q: What should a patient do if their pain doesn't improve while taking Diclo-5?

A: Patient information leaflets generally advise that if symptoms persist or if the pain does not show improvement within the duration of treatment specified by the prescriber, seeking further medical advice is recommended.

Q: Does official labeling recommend taking Diclo-5 with food?

A: Official advice varies by the exact formulation. Some oral tablets are advised to be taken before meals, and taking immediate-release forms with food can slow absorption and delay pain relief. If stomach upset is a concern, the labeling for certain delayed-release forms notes that they may be taken with food or milk.

Q: Is it normal to feel dizzy when starting Diclo-5?

A: Dizziness is listed as a common side effect in official product information. It is possible to experience this side effect as your body begins to adjust to the medication.

Q: What is the general duration of treatment for acute conditions with Diclo-5?

A: For acute uses, such as treating primary dysmenorrhea (menstrual cramps) or acute migraines, the treatment is typically limited to the shortest duration necessary to manage the acute episode. This aligns with the overall principle to minimize the length of treatment.

Q: Is it necessary to have routine blood tests while on long-term Diclo-5 therapy?

A: Due to the potential for the drug to affect liver and kidney function, official prescribing information indicates that monitoring liver enzymes (transaminases) and kidney function periodically may be necessary for patients on long-term Diclo-5 therapy.

Q: Can Diclo-5 be taken with other pain medications?

A: Official guidance strictly prohibits taking Diclo-5 alongside other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) or aspirin due to a high risk of serious stomach side effects. However, it is generally stated to be safe to take with non-NSAID pain relievers, such as paracetamol (acetaminophen) or codeine.

How should Diclo-5 be stored and disposed of?

How to Store and Dispose of Diclo-5

Official regulatory guidelines define specific storage and disposal requirements for Diclofenac (Diclo-5) products to maintain their stability and ensure safety.

Storage Requirements

Oral forms must generally be stored below 25 C or 30 C and protected from light and moisture. Topical gel must be stored at controlled room temperature (20 C to 25 C) and strictly kept from freezing. The medicine must always remain in its original container and be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Diclofenac should be discarded using a drug take-back program where available. If no take-back option is accessible, the medicine should be mixed with an undesirable substance, placed in a sealed container, and thrown into the household trash. It is required to avoid release to the environment, and unused medicine should not be flushed unless specifically instructed.

Diclo-5